To the Editor Yeh and Chang1 described the new discipline of oncocardiology as well as the opportunities for research and practice of cardiology and oncology. However, the authors failed to highlight the potential of personalized medicine. The significant strides made since the emergence of human genome sequencing has led to a fundamental shift in cancer biology and treatment.